Oculis Holding AG OCS
NASDAQ OCS
$7.84 +0.36 (+4.74%)
As of: Oct 21, 2026 · 1:39 PM EDT

Oculis Holding AG (OCS) Restructuring Costs (2023)

Updated

Oculis Holding AG (OCS) posted Restructuring Costs of -$5.19 million for FY2023, compared with -$224,333 in FY2022.

Analysis

Oculis Holding AG (OCS) Restructuring Costs (2023) Analysis & Trends

  • Business Quant data shows OCS's Restructuring Costs at -$224,333 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,134.13 Bn 1,102.72 Bn 19.71 Bn
2 Johnson & Johnson 616.20 Bn 534.73 Bn 17.26 Bn
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn
5 Novartis Ag 297.88 Bn 261.87 Bn 11.24 Bn
6 Astrazeneca 261.36 Bn 235.05 Bn 12.86 Bn
7 Amgen 235.80 Bn 191.20 Bn 7.24 Bn
8 Gilead Sciences 190.78 Bn 164.97 Bn 6.22 Bn
9 Pfizer 169.43 Bn 116.08 Bn 10.94 Bn
10 Oculis Holding AG 409.85 Mn -601.63 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 -71,325.61
Jun 30, 2023 -2.67 Mn
Mar 31, 2023 -2.31 Mn
API Access

Oculis Holding AG Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=OCS&period=max&api_key=YOUR_API_KEY